Skip to content

COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

Study to Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04318366
Acronym
COVID-BioB
Enrollment
6000
Registered
2020-03-24
Start date
2020-03-19
Completion date
2026-06-19
Last updated
2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus Infections

Brief summary

Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions

Interventions

OTHERObservational Study

Not required

Sponsors

Università Vita-Salute San Raffaele
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients admitted to hospital with biological samples positive for SARS-CoV-2 * Patients admitted to hospital with negative test but clinical and radiological characteristics highly suggestive of SARS-CoV-2 disease * Patients discharged from emergency department with biological samples positive for SARS-CoV-2

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment ResponseHospital stay (2-3 weeks)Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response

Countries

Italy

Contacts

CONTACTGiovanni Landoni, Professor
landoni.giovanni@hsr.it+390226436151
CONTACTAlberto Zangrillo, Professor
zangrillo.alberto@hsr.it+390226436151

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 9, 2026